Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

David Bailey

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Objects

Beverages

Phenomena

Food-Drug Interactions

Chemicals & Drugs

Living Beings

Physiology

Drug Interactions

Concepts & Ideas

Procedures

Disorders

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
15
Dresser, George
11
Spence, David
7
Bend, John
7
Kim, Richard
5
Schwarz, Ute
4
Freeman, David
3
Leake, Brenda
3
Kreeft, JH
3
Munoz, C
3
Tirona, Rommel
2
Lee, Wooin
2
Mayo, Gail
1
Miehlke, Stephan
1
Milstone, Aaron
1
Oertel, Reinhard

Sign-in to see all Coauthors

Publications

TOP 3
Ho Richard H; Choi Leena; Lee Wooin; Mayo Gail; Schwarz Ute I; Tirona Rommel G; Bailey David G; Michael Stein C; Kim Richard B
Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.
Bailey D G; Dresser G K; Leake B F; Kim R B
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.
Glaeser H; Bailey D G; Dresser G K; Gregor J C; Schwarz U I; McGrath J S; Jolicoeur E; Lee W; Leake B F; Tirona R G; Kim R B
Intestinal drug transporter expression and the impact of grapefruit juice in humans.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Bailey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2007: Ho Richard H; Choi Leena; Lee Wooin; Mayo Gail; Schwarz Ute I; Tirona Rommel G; Bailey David G; Michael Stein C; Kim Richard B
Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants.
Pharmacogenetics and genomics 2007;17(8):647-56.
2007: Bailey D G; Dresser G K; Leake B F; Kim R B
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice.
Clinical pharmacology and therapeutics 2007;81(4):495-502.
2007: Glaeser H; Bailey D G; Dresser G K; Gregor J C; Schwarz U I; McGrath J S; Jolicoeur E; Lee W; Leake B F; Tirona R G; Kim R B
Intestinal drug transporter expression and the impact of grapefruit juice in humans.
Clinical pharmacology and therapeutics 2007;81(3):362-70.
2006: Schwarz Ute I; Johnston Philip E; Bailey David G; Kim Richard B; Mayo Gail; Milstone Aaron
Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition.
British journal of clinical pharmacology 2006;62(4):485-91.
2006: Tirona Rommel G; Bailey David G
Herbal product-drug interactions mediated by induction.
British journal of clinical pharmacology 2006;61(6):677-81.
2005: Schwarz Ute I; Seemann Diana; Oertel Reinhard; Miehlke Stephan; Kuhlisch Eberhard; Fromm Martin F; Kim Richard B; Bailey David G; Kirch Wilhelm
Grapefruit juice ingestion significantly reduces talinolol bioavailability.
Clinical pharmacology and therapeutics 2005;77(4):291-301.
2005: Dresser George K; Kim Richard B; Bailey David G
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
Clinical pharmacology and therapeutics 2005;77(3):170-7.
2004: Bailey D G; Malcolm J; Arnold O; Spence J D
Grapefruit juice-drug interactions. 1998.
British journal of clinical pharmacology 2004;58(7):S831-40; discussion S841-3.
2004: Bailey David G; Dresser George K
Natural products and adverse drug interactions.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;170(10):1531-2.
2004: Bailey David G; Dresser George K
Interactions between grapefruit juice and cardiovascular drugs.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2004;4(5):281-97.
2003: Dresser G K; Bailey D G
The effects of fruit juices on drug disposition: a new model for drug interactions.
European journal of clinical investigation 2003;33 Suppl 2():10-6.
2003: Bailey David G; Dresser George K; Bend John R
Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Clinical pharmacology and therapeutics 2003;73(6):529-37.
2002: Dresser George K; Wacher Vincent; Wong Susan; Wong Harrison T; Bailey David G
Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo.
Clinical pharmacology and therapeutics 2002;72(3):247-55.
2002: Dresser George K; Bailey David G; Leake Brenda F; Schwarz Ute I; Dawson Paul A; Freeman David J; Kim Richard B
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
Clinical pharmacology and therapeutics 2002;71(1):11-20.
2002: Dresser George K; Bailey David G
A basic conceptual and practical overview of interactions with highly prescribed drugs.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2002;9(4):191-8.
2001: Offman E M; Freeman D J; Dresser G K; Munoz C; Bend J R; Bailey D G
Red wine-cisapride interaction: comparison with grapefruit juice.
Clinical pharmacology and therapeutics 2001;70(1):17-23.
2000: Bailey D G; Dresser G K; Kreeft J H; Munoz C; Freeman D J; Bend J R
Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.
Clinical pharmacology and therapeutics 2000;68(5):468-77.
2000: Dresser G K; Bailey D G; Carruthers S G
Grapefruit juice--felodipine interaction in the elderly.
Clinical pharmacology and therapeutics 2000;68(1):28-34.
2000: Bailey D G; Dresser G K
Grapefruit juice-lovastatin interaction.
Clinical pharmacology and therapeutics 2000;67(6):690.
2000: Dresser G K; Spence J D; Bailey D G
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.
Clinical pharmacokinetics 2000;38(1):41-57.
1998: Bailey D G; Kreeft J H; Munoz C; Freeman D J; Bend J R
Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans.
Clinical pharmacology and therapeutics 1998;64(3):248-56.
1998: Bailey D G; Malcolm J; Arnold O; Spence J D
Grapefruit juice-drug interactions.
British journal of clinical pharmacology 1998;46(2):101-10.
1997: Rau S E; Bend J R; Arnold M O; Tran L T; Spence J D; Bailey D G
Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance.
Clinical pharmacology and therapeutics 1997;61(4):401-9.
1996: Bailey D G; Bend J R; Arnold J M; Tran L T; Spence J D
Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice.
Clinical pharmacology and therapeutics 1996;60(1):25-33.
1995: Bailey D G; Arnold J M; Bend J R; Tran L T; Spence J D
Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation.
British journal of clinical pharmacology 1995;40(2):135-40.
1995: Clement J G; Bailey D G; Madill H D; Tran L T; Spence J D
The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine.
Biopharmaceutics & drug disposition 1995;16(5):415-25.
1994: Bailey D G; Arnold J M; Spence J D
Grapefruit juice and drugs. How significant is the interaction?
Clinical pharmacokinetics 1994;26(2):91-8.
1993: Bailey D G; Arnold J M; Strong H A; Munoz C; Spence J D
Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics.
Clinical pharmacology and therapeutics 1993;54(6):589-94.
1993: Bailey D G; Arnold J M; Munoz C; Spence J D
Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin.
Clinical pharmacology and therapeutics 1993;53(6):637-42.
1993: Bailey D G; Freeman D J; Melendez L J; Kreeft J H; Edgar B; Carruthers S G
Quinidine interaction with nifedipine and felodipine: pharmacokinetic and pharmacodynamic evaluation.
Clinical pharmacology and therapeutics 1993;53(3):354-9.
1991: Bayliff C D; Edington R D; Johnston L J; Shaw P W; Bailey D G
Impact of a pharmacist on the educational value of pharmaceutical industry film showings.
The Canadian journal of hospital pharmacy 1991;44(6):283-7.
1991: Bailey D G; Carruthers S G
Interaction between oral verapamil and beta-blockers during submaximal exercise: relevance of ancillary properties.
Clinical pharmacology and therapeutics 1991;49(4):370-6.
1991: Bailey D G; Spence J D; Munoz C; Arnold J M
Interaction of citrus juices with felodipine and nifedipine.
Lancet 1991;337(8736):268-9.
1989: Bailey D G; Spence J D; Edgar B; Bayliff C D; Arnold J M
Ethanol enhances the hemodynamic effects of felodipine.
Clinical and investigative medicine. Médecine clinique et experimentale 1989;12(6):357-62.
1989: Carruthers S G; Freeman D J; Bailey D G
Synergistic adverse hemodynamic interaction between oral verapamil and propranolol.
Clinical pharmacology and therapeutics 1989;46(4):469-77.
1988: Hardy B G; Bartle W R; Myers M; Bailey D G; Edgar B
Effect of indomethacin on the pharmacokinetics and pharmacodynamics of felodipine.
British journal of clinical pharmacology 1988;26(5):557-62.
1987: Carruthers S G; Bailey D G
Tolerance and cardiovascular effects of single dose felodipine/beta-blocker combinations in healthy subjects.
Journal of cardiovascular pharmacology 1987;10 Suppl 1():S169-76.

Sign-in to see more